journal cover

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect

American Journal of Physical Medicine & Rehabilitation

Oct 26, 2005

Birol BalabanTerri Carry

PMID: 16244521

Abstract

To determine and compare the long-term effects of prednisone and deflazacort on the functional status of children with Duchenne muscular dystrophy. A total of 49 boys with Duchenne muscular dystrophy, between the age of 12 and 15 yrs, who were observed over a 7-yr period were reviewed r...read more

Mentioned in this Paper

Congenital Scoliosis
Scoliosis, Unspecified
Cataract
Motor Skills
Lung
Acquired Scoliosis
Anti-Inflammatory Agents
Corticosteroid [EPC]
Upper Extremity
Zamene
Paper Details
References
  • References29
  • Citations56
123
  • References29
  • Citations56
12345...

Similar Papers Found In These Feeds

Myopathies

Myopathies are genetic or acquired disorders of skeletal muscle that lead to varying degrees of weakness, atrophy, and exercise intolerance. Here are the latest discoveries pertaining to this disease.

Muscular Dystrophy

Muscular dystrophy refers to a range of muscle diseases caused by defects in muscle proteins, leading to death of the muscle cells, with loss of muscle tissue, and weakness. Here are the latest discoveries pertaining to this disease.

Charcot-Marie-Tooth Disease (CMT)

Charcot-Marie-Tooth (CMT) disease is a hereditary motor and sensory neuropathy characterized by loss of muscle and touch sensation. Discover the latest research on CMT here.

Related Papers

Pediatric Neurology

Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up

Pediatric NeurologyFebruary 19, 2008
Sylvie HoudeMichel Vanasse
© 2020 Meta ULC. All rights reserved

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect

American Journal of Physical Medicine & Rehabilitation

Oct 26, 2005

Birol BalabanTerri Carry

PMID: 16244521

DOI:

Abstract

To determine and compare the long-term effects of prednisone and deflazacort on the functional status of children with Duchenne muscular dystrophy. A total of 49 boys with Duchenne muscular dystrophy, between the age of 12 and 15 yrs, who were observed over a 7-yr period were reviewed r...read more

Mentioned in this Paper

Congenital Scoliosis
Scoliosis, Unspecified
Cataract
Motor Skills
Lung
Acquired Scoliosis
Anti-Inflammatory Agents
Corticosteroid [EPC]
Upper Extremity
Zamene

Similar Papers Found In These Feeds

Myopathies

Myopathies are genetic or acquired disorders of skeletal muscle that lead to varying degrees of weakness, atrophy, and exercise intolerance. Here are the latest discoveries pertaining to this disease.

Muscular Dystrophy

Muscular dystrophy refers to a range of muscle diseases caused by defects in muscle proteins, leading to death of the muscle cells, with loss of muscle tissue, and weakness. Here are the latest discoveries pertaining to this disease.

Related Papers

Pediatric Neurology

Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up

Pediatric NeurologyFebruary 19, 2008
Sylvie HoudeMichel Vanasse
Paper Details
References
  • References29
  • Citations56
123
  • References29
  • Citations56
12345...
/papers/corticosteroid-treatment-and-functional/16244521